Red Flags Detected

  • Delisting (new) — Company received two separate Nasdaq deficiency notices for failing stockholders' equity requirements and board independence standards, creating immediate delisting risk.
  • Going Concern (new) — Company disclosed substantial doubt about its ability to continue as a going concern due to capital needs and liquidity constraints.
NASDAQ: TPST Tempest Therapeutics, Inc. 8-K

Tempest Therapeutics faces dual Nasdaq deficiency notices for equity shortfall and board crisis

Filed May 22, 2026 · Period ending May 19, 2026 · ~1 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade TPST commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

View original filing on SEC.gov

Generated by AI · May 24, 2026 11:05 AM